Lushang Freda Pharmaceutical Stock Forecast for 2023 - 2025 - 2030

Updated on 04/28/2024

Stock Rating
17
Price Target
¥11.65
Consensus
Outperform
Upside
43.12%
Analysts
2
Stock Rating
17
Upside
43.12%
Analysts
2
Price Target
¥11.65

Lushang Freda Pharmaceutical Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for Lushang Freda Pharmaceutical were recently set by two distinguished experts, with an average mark of ¥11.65. If it reached this goal, it would represent a potential upside of approximately 43.12% from the previous closing price in April, 2024. The high end is ¥13.00, and the low is ¥10.70. If you're considering investing in 600223 stock, it's essential to look at its competitors, too.

¥11.65

43.12% Upside

Buy
Buy

Lushang Freda Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Lushang Freda Pharmaceutical has seen a decline in its Price, from ¥11.94 to ¥0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach ¥8.67 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
¥8.67
2025 Fair Value Forecast
¥10.98
2026 Fair Value Forecast
¥11.36
2027 Fair Value Forecast
¥6.65
2028 Fair Value Forecast
¥7.68
2029 Fair Value Forecast
¥9.06
2030 Fair Value Forecast
¥10.34
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
900928 Stock Forecast Shanghai Lingang Holdings Buy 16
$11.26 Buy/Sell $17.00 50.98%
600048 Stock Forecast Poly Developments and Holdings... Outperform 18
¥8.64 Buy/Sell ¥16.97 20.37%
000002 Stock Forecast China Vanke Outperform 16
¥6.87 Buy/Sell ¥14.81 32.46%
960 Stock Forecast Longfor Group Holdings Buy 18
HK$11.00 Buy/Sell HK$17.69 9.00%
600606 Stock Forecast Greenland Holdings Corporation Sell 18
¥1.76 Buy/Sell ¥2.71 -26.14%

Lushang Freda Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Lushang Freda Pharmaceutical has seen a decline in its Revenue, from ¥13.62B to ¥12.95B – a 4.88% decrease. In the next year, analysts believe that Revenue will reach ¥13.00B – an increase of 0.35%. For the next eight years, the forecast is for Revenue to grow by 0.27%.

2023 Rev Forecast
¥13.00B
2024 Rev Forecast
¥13.22B
2025 Rev Forecast
¥12.93B
2026 Rev Forecast
¥12.94B
2027 Rev Forecast
¥12.96B
2028 Rev Forecast
¥13.05B
2029 Rev Forecast
¥13.01B
2030 Rev Forecast
¥12.99B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002244 Stock Forecast Hangzhou Binjiang Real Estate ... Buy 15
¥6.42 Buy/Sell ¥11.14 60.44%
600095 Stock Forecast Xiangcai Co.,Ltd - 14
¥7.64 Buy/Sell ¥7.50 -100.00%
600208 Stock Forecast Xinhu Zhongbao - 18
¥2.14 Buy/Sell ¥3.50 -100.00%

Lushang Freda Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Lushang Freda Pharmaceutical's Dividend per Share has decreased by 45.00%, from ¥0.20 to ¥0.11. In the next year, analysts believe that Dividend per Share will reach ¥0.13 – an increase of 18.18%. For the next seven years, experts predict that Lushang Freda Pharmaceutical's Dividend per Share will grow at a rate of 34.96%.

2024 DPS Forecast
¥0.13
2025 DPS Forecast
¥0.15
2026 DPS Forecast
¥0.16
2027 DPS Forecast
¥0.14
2028 DPS Forecast
¥0.14
2029 DPS Forecast
¥0.14
2030 DPS Forecast
¥0.15
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
601155 Stock Forecast Seazen Holdings Hold 16
¥9.11 Buy/Sell ¥15.98 9.22%
2007 Stock Forecast Country Garden Holdings Compan... Underperform 16
HK$0.49 Buy/Sell HK$0.81 6.12%
600246 Stock Forecast Vantone Neo Development Group Outperform 16
¥7.65 Buy/Sell ¥8.50 -100.00%

Lushang Freda Pharmaceutical Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
¥0.05B
2025 FCF Forecast
¥0.15B
2026 FCF Forecast
¥0.16B
2027 FCF Forecast
¥0.12B
2028 FCF Forecast
¥0.10B
2029 FCF Forecast
¥0.12B
2030 FCF Forecast
¥0.13B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
2772 Stock Forecast Zhongliang Holdings Group Comp... - 16
HK$0.31 Buy/Sell HK$0.00 -100.00%
3900 Stock Forecast Greentown China Holdings Buy 15
HK$6.00 Buy/Sell HK$10.31 49.33%
600064 Stock Forecast Nanjing Gaoke Company - 16
¥5.95 Buy/Sell ¥9.54 -100.00%

Lushang Freda Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030

Lushang Freda Pharmaceutical's EBITDA has decreased In the last two years, from ¥848.99M to ¥681.85M – a 19.69% drop. For the next year, analysts predict that EBITDA will reach ¥830.89M – an increase of 21.86%. Over the next seven years, experts believe that Lushang Freda Pharmaceutical's EBITDA will grow at a rate of 37.50%.

2024 EBITDA Forecast
¥0.83B
2025 EBITDA Forecast
¥1.01B
2026 EBITDA Forecast
¥0.98B
2027 EBITDA Forecast
¥0.87B
2028 EBITDA Forecast
¥0.87B
2029 EBITDA Forecast
¥0.91B
2030 EBITDA Forecast
¥0.94B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
2868 Stock Forecast Beijing Capital Land - 16
HK$2.78 Buy/Sell HK$2.63 13.67%
000402 Stock Forecast Financial Street Holdings Outperform 18
¥3.47 Buy/Sell ¥5.15 50.43%
000540 Stock Forecast Zhongtian Financial Group Comp... - 15
¥0.40 Buy/Sell ¥0.00 -100.00%

Lushang Freda Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Lushang Freda Pharmaceutical's EBIT has seen a drop from ¥765.96M to ¥575.66M – a 24.84% decrease. In the next year, analysts predict that EBIT will jump to ¥648.39M – up 12.63% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 33.68%.

2024 EBIT Forecast
¥0.65B
2025 EBIT Forecast
¥0.81B
2026 EBIT Forecast
¥0.82B
2027 EBIT Forecast
¥0.73B
2028 EBIT Forecast
¥0.71B
2029 EBIT Forecast
¥0.74B
2030 EBIT Forecast
¥0.77B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000048 Stock Forecast Shenzhen Kingkey Smart Agricul... Buy 16
¥18.28 Buy/Sell ¥0.00 -100.00%
9968 Stock Forecast Huijing Holdings Company - 14
HK$1.96 Buy/Sell HK$0.00 -100.00%
002146 Stock Forecast RiseSun Real Estate Developmen... - 16
¥1.59 Buy/Sell ¥0.00 -100.00%

Lushang Freda Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Lushang Freda Pharmaceutical has seen a decline in its EPS, from ¥0.62 to ¥0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach ¥0.45 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
¥0.45
2025 EPS Forecast
¥0.57
2026 EPS Forecast
¥0.59
2027 EPS Forecast
¥0.35
2028 EPS Forecast
¥0.40
2029 EPS Forecast
¥0.47
2030 EPS Forecast
¥0.54
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600158 Stock Forecast China Sports Industry Group - 17
¥8.61 Buy/Sell ¥8.22 -100.00%
3377 Stock Forecast Sino-Ocean Group Holding Hold 14
HK$0.32 Buy/Sell HK$0.00 193.75%
000631 Stock Forecast Shunfa Hengye - 15
¥3.15 Buy/Sell ¥11.47 -100.00%